Marshall Wace
PGEN icon

Marshall Wace’s Precigen PGEN Stock Holding History

Marshall Wace’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-56,963
Closed -$220K – 3597
2026
Q1 		$220K Buy
+56,963
New +$234K ﹤0.01% 2753
2025
Q4 		– Sell
-411,794
Closed -$1.35M – 3361
2025
Q3 		$1.35M Buy
411,794
+42,656
+12% +$120K ﹤0.01% 1804
2025
Q2 		$524K Buy
+369,138
New +$525K ﹤0.01% 2125
2022
Q4 		– Sell
-486,806
Closed -$1.03M – 3307
2022
Q3 		$1.03M Buy
+486,806
New +$1.03M ﹤0.01% 2385
2022
Q2 		– Sell
-591,863
Closed -$1.25M – 3743
2022
Q1 		$1.25M Buy
591,863
+575,206
+3,453% +$1.4M ﹤0.01% 2342
2021
Q4 		$62K Sell
16,657
-367,452
-96% -$1.58M ﹤0.01% 3508
2021
Q3 		$1.92M Buy
384,109
+167,207
+77% +$963K 0.01% 1590
2021
Q2 		$1.41M Buy
+216,902
New +$1.52M 0.01% 1636
2020
Q3 		– Sell
-54,327
Closed -$271K – 1839
2020
Q2 		$271K Buy
+54,327
New +$185K ﹤0.01% 1348
2016
Q3 		– Sell
-32,803
Closed -$800K – 1086
2016
Q2 		$800K Buy
+32,803
New +$931K 0.01% 752

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace's PGEN Position: Q2 2026 in Review

Marshall Wace sold out of Precigen (PGEN) in Q2 2026, closing a stake of 56,963 shares — an estimated $220K sold.

Marshall Wace first reported a position in PGEN in Q2 2016 and held it in 10 quarters. The position peaked at $1.92M in Q3 2021. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Marshall Wace reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 56,963 Precigen shares in Q2 2026, an estimated $220K.
  • Marshall Wace first reported a position in Precigen in Q2 2016 and held it in 10 quarters.
  • Marshall Wace's Precigen position peaked at $1.92M in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.